https://www.harnesstx.com/ 2026-01-26 monthly 0.5 https://www.harnesstx.com/about/ 2026-02-16 monthly 0.5 https://www.harnesstx.com/the-need/ 2026-02-06 monthly 0.5 https://www.harnesstx.com/our-platform/ 2026-02-06 monthly 0.5 https://www.harnesstx.com/our-programmes/ 2026-03-12 monthly 0.5 https://www.harnesstx.com/careers/ 2026-01-15 monthly 0.5 https://www.harnesstx.com/news/ 2022-06-28 0.5 https://www.harnesstx.com/media/ 2025-06-18 monthly 0.5 https://www.harnesstx.com/contact/ 2025-08-28 monthly 0.5 https://www.harnesstx.com/privacy-policy/ 2025-03-20 0.5 https://www.harnesstx.com/about/our-people/ 2026-02-16 monthly 0.5 https://www.harnesstx.com/about/investors/ 2026-01-15 monthly 0.5 https://www.harnesstx.com/about/company-profile/ 2026-02-06 monthly 0.5 https://www.harnesstx.com/about/our-people/our-leadership-team/ 2024-07-11 0.5 https://www.harnesstx.com/about/our-people/our-board-of-directors/ 2025-01-29 0.5 https://www.harnesstx.com/about/our-people/our-scientific-advisory-board/ 2026-02-16 monthly 0.5 https://www.harnesstx.com/about/our-people/corporate-team/ 2025-11-06 monthly 0.5 https://www.harnesstx.com/about/our-people/programme-management-operations/ 2024-12-20 0.5 https://www.harnesstx.com/about/our-people/target-lead-progression/ 2025-11-06 monthly 0.5 https://www.harnesstx.com/about/our-people/cell-molecular-biology/ 2026-04-07 weekly 0.5 https://www.harnesstx.com/about/our-people/rna-computational-biology/ 2025-11-06 monthly 0.5 https://www.harnesstx.com/about/our-people/scientific-advisors/ 2026-02-16 monthly 0.5 https://www.harnesstx.com/our-programmes/huntingtons-disease/ 2026-03-13 monthly 0.5 https://www.harnesstx.com/our-programmes/als-and-alzheimers/ 2026-03-13 monthly 0.5 https://www.harnesstx.com/our-programmes/parkinsons-disease/ 2026-03-23 weekly 0.5 https://www.harnesstx.com/news/harness-therapeutics-nominates-hrn001-a-first-in-class-drug-candidate-for-huntingtons-disease-and-establishes-clinical-advisory/ 2026-02-16 monthly 0.5 https://www.harnesstx.com/news/harness-therapeutics-announces-launch-of-misba-duo-platform-and-research-collaboration-with-ono-venture-investment/ 2025-10-06 monthly 0.5 https://www.harnesstx.com/news/harness-therapeutics-publishes-htt-cag-repeat-sizing-methodology-code-on-github/ 2025-06-05 monthly 0.5 https://www.harnesstx.com/news/harness-therapeutics-to-present-nanopore-sequencing-data-for-detecting-cag-expansion-in-the-huntingtin-gene-at-chdi-huntingtons/ 2025-02-25 0.5 https://www.harnesstx.com/news/harness-therapeutics-appoints-dr-heather-preston-as-chair-and-secures-new-funding-from-ono-venture-investment-to-accelerate/ 2025-01-27 0.5 https://www.harnesstx.com/news/harness-therapeutics-appoints-experienced-r-d-executive-and-physician-scientist-dr-paulo-fontoura-as-non-executive-director/ 2024-09-03 0.5 https://www.harnesstx.com/news/harness-therapeutics-appoints-leading-world-experts-in-neurodegenerative-diseases-to-its-scientific-advisory-board-sab/ 2024-05-30 0.5 https://www.harnesstx.com/news/harness-attend-target-als-annual-meeting/ 2024-05-08 0.5 https://www.harnesstx.com/news/harness-therapeutics-appoints-seasoned-biopharmaceutical-leader-ms-meenu-chhabra-karson-as-board-chair/ 2024-04-24 0.5 https://www.harnesstx.com/news/harness-attend-the-19th-annual-huntingtons-disease-therapeutics-conference/ 2024-02-21 0.5 https://www.harnesstx.com/news/our-new-website-is-live/ 2023-12-21 0.5 https://www.harnesstx.com/news/harness-attending-biotech-showcase-2024/ 2023-12-21 0.5 https://www.harnesstx.com/news/harness-therapeutics-secures-additional-4-million-funding-to-pursue-physiological-upregulation-approach-to-treat/ 2023-11-28 0.5 https://www.harnesstx.com/media/bio-europe-spring-in-lisbon/ 2026-03-27 weekly 0.5 https://www.harnesstx.com/media/international-conference-on-alzheimers-and-parkinsons-disease-ad-pd-2026-in-copenhagen/ 2026-03-27 weekly 0.5 https://www.harnesstx.com/media/huntingtons-disease-gratitude-day/ 2026-03-27 weekly 0.5 https://www.harnesstx.com/media/international-womens-day/ 2026-03-27 weekly 0.5 https://www.harnesstx.com/media/advancing-huntingtons-disease-research-harness-at-the-21st-annual-chdi-foundation-therapeutics-conference/ 2026-03-27 weekly 0.5 https://www.harnesstx.com/media/rare-disease-day/ 2026-03-27 weekly 0.5 https://www.harnesstx.com/media/eqt-group-life-sciences-biocapital-europe-in-amsterdam/ 2026-03-27 weekly 0.5 https://www.harnesstx.com/media/harness-therapeutics-nominates-hrn001-a-first-in-class-drug-candidate-for-huntingtons-disease-and-establishes-clinical-advisory/ 2026-03-27 weekly 0.5 https://www.harnesstx.com/media/visit-from-charles-sabine-obe/ 2026-03-27 weekly 0.5 https://www.harnesstx.com/media/chdi-foundations-annual-huntingtons-disease-therapeutics-conference/ 2026-03-27 weekly 0.5 https://www.harnesstx.com/media/44th-annual-j.p-morgan-healthcare-conference/ 2026-03-27 weekly 0.5 https://www.harnesstx.com/media/london-at-the-nextgen-omics-spatial-and-data-symposium-2025/ 2026-03-27 weekly 0.5 https://www.harnesstx.com/media/jeffries-global-healthcare-conference-in-london/ 2026-03-27 weekly 0.5 https://www.harnesstx.com/media/bio-europe-2025/ 2025-11-11 monthly 0.5 https://www.harnesstx.com/media/elrig-drug-discovery-2025-conference/ 2025-10-21 monthly 0.5 https://www.harnesstx.com/media/harness-attends-hd-clinical-research-congress/ 2025-10-14 monthly 0.5 https://www.harnesstx.com/media/valuable-connections-at-the-european-huntington-association-conference/ 2025-10-03 monthly 0.5 https://www.harnesstx.com/media/harness-attend-the-european-huntington-associations-eha-5th-biannual-conference/ 2025-10-02 monthly 0.5 https://www.harnesstx.com/media/edison-cns-report/ 2025-09-26 monthly 0.5 https://www.harnesstx.com/media/harness-attends-rna-leaders-usa-congress/ 2025-09-10 monthly 0.5 https://www.harnesstx.com/media/treating-neurodegenerative-diseases/ 2025-09-02 monthly 0.5 https://www.harnesstx.com/media/hd-buzz-article/ 2025-09-02 monthly 0.5 https://www.harnesstx.com/media/springer-nature-research/ 2025-08-27 monthly 0.5 https://www.harnesstx.com/media/employee-spotlight-laura-grasso-principal-scientist/ 2025-08-21 monthly 0.5 https://www.harnesstx.com/media/tribute-to-ozzy-osbourne/ 2025-08-07 monthly 0.5 https://www.harnesstx.com/media/harness-summer-social/ 2025-08-07 monthly 0.5 https://www.harnesstx.com/media/gradiant-partnership/ 2025-08-07 monthly 0.5 https://www.harnesstx.com/media/max-brennan-podcast/ 2025-08-07 monthly 0.5 https://www.harnesstx.com/media/biobabraham-symposium/ 2025-06-25 monthly 0.5 https://www.harnesstx.com/media/lsx-world-congress-europe/ 2025-04-28 0.5 https://www.harnesstx.com/media/synuclein-meeting-2025/ 2025-04-28 0.5 https://www.harnesstx.com/media/stem-cell-models-of-neurodegeneration-international-symposium/ 2025-04-29 0.5 https://www.harnesstx.com/media/huntingtons-disease-youth-organization-hdyo-international-young-adults-congress/ 2025-04-29 0.5 https://www.harnesstx.com/media/bio-europe-spring/ 2025-04-29 0.5 https://www.harnesstx.com/media/bia-women-in-biotech-conference/ 2025-04-29 0.5 https://www.harnesstx.com/media/lsx-rna-leaders-europe-congress-basel/ 2025-04-28 0.5 https://www.harnesstx.com/media/the-entrepreneurship-careers-network-event/ 2025-04-29 0.5 https://www.harnesstx.com/media/odds-and-socks-day/ 2025-04-29 0.5 https://www.harnesstx.com/media/exploring-the-potential-of-nanopore-sequencing-for-detecting-cag-expansion-in-htt-gene/ 2025-04-28 0.5 https://www.harnesstx.com/media/heather-preston-visits/ 2025-04-29 0.5 https://www.harnesstx.com/media/cell-and-nature-paper/ 2025-06-24 monthly 0.5